You just read:

Lilly to Present Clinical Data for Verzenio® (abemaciclib) and Real-World Evidence across HR+, HER2- Metastatic Breast Cancer at 2018 SABCS

News provided by

Eli Lilly and Company

Nov 29, 2018, 06:45 ET